Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Panobinostat (Primary)
- Indications Glioma
- Focus Adverse reactions; Pharmacokinetics
- 21 Sep 2017 Protocol has been amended to change in the Treatment arm and primary endpoint.
- 21 Sep 2017 Planned number of patients changed from 20 to 40.
- 25 Aug 2017 Planned End Date changed from 1 Feb 2019 to 1 Oct 2019.